Southland Equity Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
6,575
+297
| +5% | +$20.5K | 0.1% | 137 |
|
|
2025
Q1 | $436K | Buy |
6,278
+362
| +6% | +$25.1K | 0.1% | 135 |
|
|
2024
Q4 | $509K | Buy |
5,916
+338
| +6% | +$29.1K | 0.12% | 120 |
|
|
2024
Q3 | $664K | Buy |
5,578
+37
| +0.7% | +$4.41K | 0.16% | 95 |
|
|
2024
Q2 | $791K | Buy |
5,541
+1
| +0% | +$143 | 0.23% | 74 |
|
|
2024
Q1 | $711K | Buy |
5,540
+113
| +2% | +$14.5K | 0.2% | 76 |
|
|
2023
Q4 | $561K | Buy |
5,427
+147
| +3% | +$15.2K | 0.18% | 82 |
|
|
2023
Q3 | $480K | Buy |
5,280
+120
| +2% | +$10.9K | 0.17% | 84 |
|
|
2023
Q2 | $418K | Buy |
5,160
+38
| +0.7% | +$3.08K | 0.14% | 102 |
|
|
2023
Q1 | $408K | Sell |
5,122
-10
| -0.2% | -$796 | 0.16% | 101 |
|
|
2022
Q4 | $347K | Buy |
5,132
+116
| +2% | +$7.85K | 0.13% | 108 |
|
|
2022
Q3 | $250K | Sell |
5,016
-8
| -0.2% | -$399 | 0.12% | 127 |
|
|
2022
Q2 | $280K | Buy |
5,024
+188
| +4% | +$10.5K | 0.13% | 124 |
|
|
2022
Q1 | $269K | Sell |
4,836
-54
| -1% | -$3K | 0.11% | 138 |
|
|
2021
Q4 | $274K | Buy |
4,890
+34
| +0.7% | +$1.9K | 0.11% | 138 |
|
|
2021
Q3 | $233K | Buy |
4,856
+76
| +2% | +$3.65K | 0.11% | 145 |
|
|
2021
Q2 | $200K | Buy |
+4,780
| New | +$200K | 0.09% | 158 |
|